These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24781065)

  • 61. [Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
    Karasawa H; Miwa T
    Nihon Rinsho; 1992 Jan; 50(1):74-80. PubMed ID: 1347333
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
    Yang Z; Wu Q; Liu Z; Wu K; Fan D
    Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The new algorithm of diagnostics, prevention and treatment of acute erosive and ulcerative lesions of the gastrointestinal tract].
    Dzhitava IG; Smirnova GO; Martirosov AV
    Eksp Klin Gastroenterol; 2011; (5):63-8. PubMed ID: 21916237
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of antisecretory agents for gastric endoscopic submucosal dissection.
    Fujishiro M; Chiu PW; Wang HP
    Dig Endosc; 2013 Mar; 25 Suppl 1():86-93. PubMed ID: 23368844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Histamine H2-receptor antagonists.
    Feldman M; Richardson CT
    Adv Intern Med; 1978; 23():1-24. PubMed ID: 24327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The impact of antisecretory therapy on gastroduodenal ulcers healing after acute bleeding].
    Barinov ÉF; Kondratenko PG; Sulaeva ON; Zharikov SO; Radenko EE; Tverdokhleb TA
    Khirurgiia (Mosk); 2014; (3):15-9. PubMed ID: 24781065
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.